No abstract available
MeSH terms
-
Antibodies, Monoclonal* / adverse effects
-
Antibodies, Monoclonal* / therapeutic use
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Carcinoma, Transitional Cell* / drug therapy
-
Humans
-
Urinary Bladder Neoplasms / drug therapy
-
Urologic Neoplasms* / drug therapy
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
enfortumab vedotin
-
pembrolizumab